| ECCO guidelines on therapeutics in Crohn's disease: medical treatment J Torres, S Bonovas, G Doherty, T Kucharzik, JP Gisbert, T Raine, ... Journal of Crohn's and Colitis 14 (1), 4-22, 2020 | 1133 | 2020 |
| Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines J Panes, Y Bouhnik, W Reinisch, J Stoker, SA Taylor, DC Baumgart, ... Journal of Crohn's and Colitis 7 (7), 556-585, 2013 | 746 | 2013 |
| Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells G Monteleone, L Biancone, R Marasco, G Morrone, O Marasco, F Luzza, ... Gastroenterology 112 (4), 1169-1178, 1997 | 724 | 1997 |
| Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract I Monteleone, A Rizzo, M Sarra, G Sica, P Sileri, L Biancone, ... Gastroenterology 141 (1), 237-248. e1, 2011 | 626 | 2011 |
| Bioactive IL-18 expression is up-regulated in Crohn’s disease G Monteleone, F Trapasso, T Parrello, L Biancone, A Stella, R Iuliano, ... The Journal of Immunology 163 (1), 143-147, 1999 | 522 | 1999 |
| ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment M Adamina, S Bonovas, T Raine, A Spinelli, J Warusavitarne, A Armuzzi, ... Journal of Crohn's and Colitis 14 (2), 155-168, 2020 | 481 | 2020 |
| Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn’s disease G Monteleone, MF Neurath, S Ardizzone, A Di Sabatino, MC Fantini, ... New England Journal of Medicine 372 (12), 1104-1113, 2015 | 480 | 2015 |
| European evidence-based consensus: inflammatory bowel disease and malignancies V Annese, L Beaugerie, L Egan, L Biancone, C Bolling, C Brandts, ... Journal of Crohn's and Colitis 9 (11), 945-965, 2015 | 456 | 2015 |
| Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis DS Kotlyar, JD Lewis, L Beaugerie, A Tierney, CM Brensinger, JP Gisbert, ... Clinical Gastroenterology and Hepatology 13 (5), 847-858. e4, 2015 | 423 | 2015 |
| Interleukin-21 enhances T-helper cell type I signaling and interferon-γ production in Crohn’s disease G Monteleone, I Monteleone, D Fina, P Vavassori, GDV Blanco, R Caruso, ... Gastroenterology 128 (3), 687-694, 2005 | 404 | 2005 |
| European evidence based consensus on surgery for ulcerative colitis T Øresland, WA Bemelman, GM Sampietro, A Spinelli, A Windsor, ... Journal of Crohn's and Colitis 9 (1), 4-25, 2015 | 390 | 2015 |
| Advanced age is an independent risk factor for severe infections and mortality in patients given anti–tumor necrosis factor therapy for inflammatory bowel disease M Cottone, A Kohn, M Daperno, A Armuzzi, L Guidi, R D'Inca, F Bossa, ... Clinical Gastroenterology and Hepatology 9 (1), 30-35, 2011 | 378 | 2011 |
| Infliximab reduces endoscopic, but not clinical, recurrence of Crohn’s disease after ileocolonic resection M Regueiro, BG Feagan, B Zou, J Johanns, MA Blank, M Chevrier, ... Gastroenterology 150 (7), 1568-1578, 2016 | 326 | 2016 |
| European evidence-based consensus on the management of ulcerative colitis: special situations L Biancone, P Michetti, S Travis, JC Escher, G Moser, A Forbes, ... Journal of Crohn's and Colitis 2 (1), 63-92, 2008 | 320 | 2008 |
| Immunoregulation in the gut: success and failures in human disease I Monteleone, P Vavassori, L Biancone, G Monteleone, F Pallone Gut 50 (suppl 3), iii60-iii64, 2002 | 214 | 2002 |
| Fecal and mucosal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease A Lo Presti, F Zorzi, F Del Chierico, A Altomare, S Cocca, A Avola, ... Frontiers in microbiology 10, 1655, 2019 | 206 | 2019 |
| Infliximab in severe ulcerative colitis: short‐term results of different infusion regimens and long‐term follow‐up A Kohn, M Daperno, A Armuzzi, M Cappello, L Biancone, A Orlando, ... Alimentary pharmacology & therapeutics 26 (5), 747-756, 2007 | 203 | 2007 |
| Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the … F Pallone, S Fais, O Squarcia, L Biancone, P Pozzilli, M Boirivant Gut 28 (6), 745-753, 1987 | 199 | 1987 |
| Infliximab and newly diagnosed neoplasia in Crohn’s disease: a multicentre matched pair study L Biancone, A Orlando, A Kohn, E Colombo, R Sostegni, E Angelucci, ... Gut 55 (2), 228-233, 2006 | 181 | 2006 |
| A novel diagnostic tool for detecting functional patency of the small bowel: the Given patency capsule C Spada, G Spera, M Riccioni, L Biancone, L Petruzziello, A Tringali, ... Endoscopy 37 (09), 793-800, 2005 | 176 | 2005 |
